Articles tagged with Cancer Cells
Researchers at Johns Hopkins University have discovered that cancer cells do not follow a 'drunken' walk through the body, but rather move in more direct lines. This new understanding could lead to more accurate results for scientists studying how cancer spreads and may lead to more effective treatments.
Researchers from Imperial College London have discovered that blocking Hhat slows pancreatic cancer growth by preventing Hedgehog from stimulating nearby cells. The study found that genetic techniques could prevent the process from starting in the first place, leading to reduced cancer cell growth and ability to spread.
Researchers found that a common mutation activates the Akt pathway, rendering cells resistant to chemotherapy and increasing growth. Inhibition of this pathway restored leukemic cell responses to front-line therapy.
A team of researchers has created a detailed analysis of protein activity in human cancer cells, revealing the dynamic patterns of gene expression during the cell cycle. The study provides new insights into how genes work over time in cancer cells and could lead to the development of safer new drugs.
A team of researchers at New York University and the University of Texas at Austin has discovered that carbohydrates serve as unique identifiers for cancer cells. By analyzing the role of microRNA in regulating carbohydrate structures, the study reveals a new way to detect cancer using sugar-based biomarkers.
Researchers have discovered that some tumors behave less aggressively in microgravity compared to on Earth, sparking hope for new cancer treatments. The unique conditions of space exploration offer insights into genetic and cellular processes that cannot be replicated on land.
A new study by Rutgers researchers reveals that eliminating the eEF2K enzyme could strengthen healthy cells, making them resilient to cancer treatment. This breakthrough may lead to more powerful treatments with fewer debilitating side effects, paving the way for improved cancer therapies.
Scientists at DESY's PETRA III research light source used nanodiffraction to study living cancer cells, showing clear differences in their internal structures compared to chemically fixed cells. The technique enabled the investigation of living cells in their natural environment using hard X-rays.
Researchers at Fox Chase Cancer Center have discovered a new mechanism of gene regulation that involves the modification of histones, leading to the activation of PARP1 and exposure of specific genes. This finding has significant implications for cancer treatment and may lead to the development of more effective therapies.
Researchers have discovered caffeine-based gold compounds that selectively kill human ovarian cancer cells without harming healthy cells. The new compounds target a specific DNA architecture associated with cancer, offering a potential tool in the fight against cancer.
Researchers at Argonne National Laboratory developed a hard X-ray fluorescence nanoprobe that preserves the natural state of cells and trace elements by rapidly cooling them to -260°F. This enables the creation of high-resolution images with unprecedented detail, solving long-standing issues in biological imaging.
Research reveals that Mdm2 suppresses tumor growth by inhibiting glycolysis through the degradation of PGAM. This process prevents cells from entering senescence and allows them to continue proliferating. The study provides new insights into how damaged cells respond to stress and offers potential avenues for cancer treatment.
Tc toxin complexes, used by bacteria like Yersinia pestis and Photorhabdus luminescens, have been imaged with atomic detail. The complexes use an elastic band-like protein chain to penetrate cell membranes, depositing toxic enzymes. This mechanism has potential applications in medicine, including selectively targeting cancer cells.
A new study at the University of Liverpool explains how cells adapt to low oxygen environments, potentially controlling cell survival signals. By monitoring protein levels and gene expression, researchers discovered optimal conditions for keeping cells alive, which could lead to cancer treatment advancements.
Researchers at Karolinska Institutet have identified a new drug candidate, VLX600, that selectively kills dormant cancer cells in solid tumors by starving them. The drug works by inhibiting mitochondrial respiration, causing the cells to die from starvation. A clinical study is planned to take place this year.
Kidney cancer cells exhibit distinct metabolic differences compared to other cancers, providing a potential weak link for diagnosis and treatment. This discovery opens the door to new biomarkers and therapeutic approaches for detecting kidney cancer at an early stage.
Researchers have developed 'smart' gold nanoshells that target cancer cells specifically, delivering anticancer drugs and converting near-infrared light into heat. This breakthrough could lead to more effective cancer treatments by overcoming the limitation of traditional chemotherapy techniques.
Researchers have discovered how the protein Bcl-2 signals cancer cells to live longer by altering calcium ion levels. This breakthrough could lead to new drugs targeting Bcl-2 and improve cancer treatment outcomes.
Researchers at the University of Adelaide found that grape seed extract improves chemotherapy's potency and reduces intestinal damage in laboratory studies. Grape seed extracts showed no side effects on healthy intestine, decreased inflammation by up to 55%, and increased growth-inhibitory effects on colon cancer cells.
Researchers at NIST developed a new method to accurately measure changes in living cell redox potential, which can serve as an indicator of cellular health and function. The technique uses nuclear magnetic resonance spectroscopy to detect glutathione levels and monitor intracellular redox reactions.
Innate lymphoid cells play key roles in protecting against infection or parasites, but their origin and function were unknown until now. Researchers identify ILCPs in fetal liver and adult bone marrow, paving the way for a better understanding of the immune system's first line of defense.
Researchers have developed a new live-cell printing technology called BloC-Printing that can print living cells onto any surface in a grid-like formation. The technology, which manipulates microfluidic physics to guide cells into hook-like traps, produces high survival rates of over 100% compared to traditional inkjet printing.
Researchers successfully controlled nanomotors inside live human cells, powered by ultrasonic waves and steered magnetically. The ability to manipulate cells from the inside holds promise for treating diseases such as cancer.
Researchers aim to make blood cancers more vulnerable to treatment by targeting the hiding spots where leukemia cells reside. Initial focus is on blood vessels, which provide a safe haven for these cells.
Researchers studied how a protein complex called Mre11-Rad50 reshapes itself to take on different DNA-repair tasks, revealing insights into its dynamic structure and biological outcomes. The findings could guide the development of better cancer-fighting therapies and more effective gene therapies.
Researchers found that aggressive thyroid cancer cells in microgravity exhibit a redifferentiation to a less aggressive state, offering hope for new treatments. The study's findings suggest potential therapeutic targets for cancer drugs that may be effective on Earth.
Researchers discovered that DNA damage triggers dramatic reorganization of the Golgi, leading to its dispersal throughout the cell. This dispersal involves a novel signaling pathway directly linking DNA damage response to the Golgi, affecting cell survival and chemotherapy efficacy.
A study by Virginia Tech researchers reveals that brain tumor cells with diverse physical traits are safer due to chromosomal abnormalities. These abnormalities lead to cell diversity and survival of brain tumors.
Researchers discovered a targeted treatment's mechanism of action, which involves the PML/p53 pathway and senescence. The treatment's effectiveness relies on reorganizing nuclear bodies and triggering p53 activation, leading to the elimination of cancer cells and patient recovery.
Researchers from University of Copenhagen develop method for slow release drugs by attaching liquid crystalline particles to cancer cells. The particles can carry large quantities of drugs and interact with cellular membranes, providing a potential solution to frequent injections and side effects.
Researchers at the University of Edinburgh have discovered a set of proteins that stabilise cell division, which could lead to new avenues in drug discovery for fighting cancer. The findings shed light on how cells duplicate their DNA and separate into two new cells, each identical to the original.
A new study suggests that autophagy plays a key role in determining the fate of cancer cells when treated with anti-cancer drugs. Cells with high levels of autophagy were more susceptible to death from certain drugs, while those with low levels of autophagy were more resistant.
The study reveals that E6AP is composed of three distinct protein molecules, controlling nerve cell function and viral replication. This breakthrough provides potential drug targets for autism and cervical cancer treatment.
Researchers found that activating p53 in normal cells induces Par-4 secretion, killing cancer cells. The paracrine effect targets tumor cells at distant sites, offering a new approach to treating tumors resistant to other treatments.
Researchers have discovered that a cancer drug can protect the insulin-producing cells in the pancreas and prevent the development of type 1 diabetes in mice. The medication works by reducing sterile inflammation and delaying cell destruction. This finding is a step towards developing a preventive treatment for type 1 diabetes.
Walter and Eliza Hall Institute researchers discovered that lymphoma cells with high levels of MYC are sensitive to disabling protein MCL-1, making it a potential target for treating cancers driven by this common cancer-causing change in cells.
Researchers at Cornell University have discovered a new way to destroy metastasizing cancer cells by hitching killer proteins to white blood cells. The treatment, which uses E-selectin and TRAIL proteins, was found to be nearly 100% effective in killing cancer cells in laboratory tests.
Researchers at the University of California, San Diego School of Medicine found that combining ROR1 and TCL1 oncogenes in mice accelerates and worsens blood cancer. The study suggests ROR1 could be an important therapeutic target for patients with CLL, a common form of blood cancer affecting over 15,000 new cases annually.
Scientists at the University of Exeter have identified four distinct routes for cell division, which could lead to errors in cell division and increase cancer risk. The study also found a central molecular complex, Augmin, essential for all these pathways.
Researchers at UT Southwestern Medical Center identified BRD4 as a potential therapeutic target for MPNST, a rare and aggressive type of soft-tissue cancer. Inhibiting BRD4 caused cancer cells to die in a mouse model, providing new hope for patients with this incurable disease.
Researchers develop new treatment for pancreatic cancer by using a drug that breaks down the protective barrier surrounding cancer tumours. The approach enables T cells to get through and kill cancer cells, resulting in almost complete elimination of cancer cells in initial tests.
A study in the Journal of Dairy Science found that polyphenol EGCG in milk can reduce colon cancer cell proliferation and inhibit tumor formation. Milk's casein protein micelles may enhance bioavailability and efficacy of these compounds.
Research reveals that fusion between cancer cells and macrophages empowers cancer cells to spread, forming tumors more rapidly. The study's findings suggest a new mechanism by which cancer progression is driven.
Researchers identify two therapeutic targets to block cancer cell growth: PAK and STAT5. The shutdown of either target significantly delays leukemia progression in mice, offering new hope for cancer treatment.
A research group at Lund University has shown that the 'avalanche effect' theory of cancer development is not correct. Cancer cells can have over 100 chromosomes, but a single initial change does not lead to unstoppable further mutations.
A toxin linked to brentuximab vedotin has shown compelling antitumor activity in patients with non-Hodgkin lymphomas, including diffuse large B cell lymphoma. The study found that 40% of DLBCL patients had an objective response, with a median duration of 36 weeks.
Scientists at VTT Technical Research Centre of Finland have discovered a novel DNA repair mechanism in cancer cells that allows them to survive DNA damage. This finding provides valuable insights into how cancer cells evade programmed cell death and can be targeted by new cancer therapies.
A new optical sensor created at MIT can track zinc within cells, shedding light on its functions and helping researchers study zinc trafficking in prostate cells. The sensor supports the theory that cancerous prostate cells banish zinc from mitochondria to produce extra energy.
A personalized cell therapy reprograms a patient's immune system to eliminate tumors in blood, showing complete responses in 89% of patients with high-risk ALL. The treatment has also been shown to persist in circulation and prevent cancer recurrence.
Researchers have discovered that tumour cells adopt the 'break-induced replication' (BIR) pathway to repair damaged replication forks, allowing for genome duplication. This pathway is common in cancer cells but rare in healthy cells, revealing a significant difference between these two types of cells.
Researchers at the University of Colorado have synthesized the most active component of grape seed extract, B2G2, which induces apoptosis in prostate cancer cells while leaving healthy cells unharmed. The findings suggest that B2G2 is a promising lead compound for future clinical trials and preclinical studies.
Researchers found that inhibiting antioxidant proteins reduced tumor growth and induced cell death in lung cancer cells. In a mouse model, the inhibitor ATN-224 also reduced tumor sizes when combined with another drug.
Researchers discovered a unique leukemia-specific DNA enhancer element that enables cancerous blood cells to proliferate in Acute Myeloid Leukemia (AML), a devastating and incurable cancer. The study also reveals how a new class of promising drugs, including JQ1, halt the growth of cancer cells by targeting this enhancer element.
Researchers have unveiled a biological process that explains how DNA can be damaged during genome replication, which relies on protein RPA. Cells use this protein as 'band aids' to protect DNA temporarily during replication, but if they run out, DNA breaks severely and cells cannot divide.
A new technique, deformability cytometry, can analyze over 1,000 cells per second and provide more accurate diagnoses than traditional methods. The test uses fluid flow to 'squeeze' individual cells, allowing for detailed analysis of cell properties.
Researchers at the University of Adelaide have discovered a gene that plays a crucial role in suppressing lymphoma, a type of blood cell cancer. Caspase-2 helps maintain healthy chromosome numbers in cells, preventing them from becoming cancerous.
Researchers used DNA sequencing to create a family tree for individual cancer cells, revealing unique branching patterns and distinct sub-populations. This technique could help identify key mutations driving tumor growth and develop targeted treatments more effectively.
Researchers have identified FOX01 as a critical molecule in the wound-healing process, providing a possible new target for pharmaceuticals. The study found that FOX01 plays an integral role in activating key growth factor TGF-β1 and protecting cells against oxidative stress.
A CNIO team has discovered that senescence, which makes cells stop dividing, also takes place during embryo development to eliminate unnecessary cells. This process, known as programmed senescence, helps shape the body's tissues and organs.
A peptide fragment derived from cow's milk, lactoferricin B25, exhibits potent anticancer capability against human stomach cancer cell cultures. This finding provides support for the potential therapeutic agent for gastric cancer treatment.